跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ATACAND PLUS 32/12.5 candesartan cilexetil & hydrochlorothiazide 32 mg/12.5 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ATACAND PLUS 32/12.5 candesartan cilexetil & hydrochlorothiazide 32 mg/12.5 mg tablet blister pack
Approved
STANDARD
ATACAND PLUS 32/12.5 candesartan cilexetil & hydrochlorothiazide 32 mg/12.5 mg tablet blister pack
Link Medical Products Pty Ltd T/A Link Pharmaceuticals
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
f0c296a130fbc7c9
Company
Link Medical Products Pty Ltd T/A Link Pharmaceuticals
Type
Standard
Approval Details
Approval Id
f0c296a130fbc7c9
Product Name
ATACAND PLUS 32/12.5 candesartan cilexetil & hydrochlorothiazide 32 mg/12.5 mg tablet blister pack
Artg Id
154247
Artg Name
ATACAND PLUS 32/12.5 candesartan cilexetil & hydrochlorothiazide 32 mg/12.5 mg tablet blister pack
Sponsor
Link Medical Products Pty Ltd T/A Link Pharmaceuticals
Artg Date
2009-09-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/49ed1c28df552a5e3c2a0cfa31527038.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c1f780d17bee272c019df1ad690cb88f.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
f0c296a130fbc7c9
Type
Standard
Back to TGA Approvals